( : Eli Lilly Investor Relations) 3 ,
It is important to understand that these in vitro models express a different hormonal cocktail and respond to different chemical stimuli than intestinal L-cells in vivo ( The more physiologically relevant studies make use of in vivo transgenic mice, ex vivo perfused intestines or, more recently, crypt organoids derived from human, mouse or porcine guts ( In situ immunostaining and FACS studies have demonstrated that the hormonal secretome of GLP-1-secreting-cells is anatomically dependent
Formenti, S
Investors excitement about the huge potential of novel AOMs propelled the valuations of Novo Nordisk and Lilly to record levels in 2024, with Lillys market cap reaching an all-time high of $912Bn on 30th August, the closest any biopharma company has come to the exclusive $1-trillion valuation
They can affect the survival, proliferation, metastasis, recurrence, drug resistance, and other functions of tumor cells through altering the function, activity, subcellular localization, protein-protein interactions, protein stability, other modification levels of non-histone proteins, and modifying histones to change gene expression, chromatin accessibility, transcriptional activity, all of which are closely related to the initiation and progression of tumors
